As a new generation of cancer drugs continues to extend the lives of people with cancer, strategies for recording and managing their toxicity and long-term effects will need innovation too. Recent breakthroughs in cancer therapy, including immunotherapies, antibody–drug conjugates and bispecific antibodies, have transformed oncology care. Cancer therapy has become more targeted to the patients’ tu...